bioRxivCancer Biology
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
T. Cokelaer, E. Chen, F. Iorio, M. P. Menden, H. Lightfoot, J. Saez-Rodriguez, G. J. Mathew
Abstract
MotivationLarge pharmacogenomic screenings integrate heterogeneous cancer genomic data sets as well as anti-cancer drug responses on thousand human cancer cell lines. Mining this data to identify new therapies for cancer sub-populations would benefit from common data structures, modular computational biology tools and user-friendly interfaces.\n\nResultsWe have developed GDSCTools: a software aimed at the identification of clinically relevant genomic markers of drug response. The Genomics of Drug Sensitivity in Cancer (GDSC) database (www.cancerRxgene.org) integrates heterogeneous cancer genomic data sets as well as anti-cancer drug responses on a thousand cancer cell lines. Including statistical tools (ANOVA) and predictive methods (Elastic Net), as well as common data structures, GDSCTools allows users to reproduce published results from GDSC, to analyse their own drug responses or genomic datasets, and to implement new analytical methods.\n\nContactthomas.cokelaer@pasteur.fr
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines
M. Boeschen, S. Horn, … T. Schönberg·bioRxiv·Aug 22, 2022
- Revisiting inconsistency in large pharmacogenomic studies
Zhaleh Safikhani, Mark Freeman, … Benjamin Haibe-Kains·F1000ResearchPeer-reviewed·Aug 11, 2017
- Predicting Cancer Drug Response Using a Recommender System
Chayaporn Suphavilai, Denis Bertrand, Niranjan Nagarajan·BioinformaticsPeer-reviewed·May 31, 2018
- An integrative resource for investigating genetic model of drug response in cancer
Yi Guo, Xiang Chen·bioRxiv·Nov 15, 2019
- Integrative analysis of pharmacogenomics in major cancer cell line databases using CellMinerCDB
Vinodh N. Rajapakse, Augustin Luna, … Yves G. Pommier·bioRxiv·Apr 2, 2018
- Assessment of pharmacogenomic agreement
Zhaleh Safikhani, Nehme El-Hachem, … Benjamin Haibe-Kains·F1000ResearchPeer-reviewed·May 9, 2016